Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis.

Moelants EA, Loozen G, Mortier A, Martens E, Opdenakker G, Mizgalska D, Szmigielski B, Potempa J, Van Damme J, Teughels W, Proost P.

Infect Immun. 2014 Jun;82(6):2511-9. doi: 10.1128/IAI.01624-14. Epub 2014 Mar 31.

2.

Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.

Abdullah SN, Farmer EA, Spargo L, Logan R, Gully N.

Anaerobe. 2013 Oct;23:102-8. doi: 10.1016/j.anaerobe.2013.07.001. Epub 2013 Jul 13.

PMID:
23856045
3.

Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, Kinloch A, Culshaw S, Potempa J, Venables PJ.

Arthritis Rheum. 2010 Sep;62(9):2662-72. doi: 10.1002/art.27552.

4.

Gingipains from Porphyromonas gingivalis play a significant role in induction and regulation of CXCL8 in THP-1 cells.

Jayaprakash K, Khalaf H, Bengtsson T.

BMC Microbiol. 2014 Jul 18;14:193. doi: 10.1186/1471-2180-14-193.

5.

Effect of Porphyromonas gingivalis on citrullination of proteins by macrophages in vitro.

Marchant C, Smith MD, Proudman S, Haynes DR, Bartold PM.

J Periodontol. 2013 Sep;84(9):1272-80. doi: 10.1902/jop.2012.120103. Epub 2012 Oct 29.

PMID:
23106505
6.

Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage.

Pyrc K, Milewska A, Kantyka T, Sroka A, Maresz K, Kozieł J, Nguyen KA, Enghild JJ, Knudsen AD, Potempa J.

Infect Immun. 2013 Jan;81(1):55-64. doi: 10.1128/IAI.00830-12. Epub 2012 Oct 22.

7.

Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.

Stobernack T, Glasner C, Junker S, Gabarrini G, de Smit M, de Jong A, Otto A, Becher D, van Winkelhoff AJ, van Dijl JM.

J Proteome Res. 2016 Dec 2;15(12):4532-4543. Epub 2016 Oct 19.

PMID:
27712078
8.

Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.

Bielecka E, Scavenius C, Kantyka T, Jusko M, Mizgalska D, Szmigielski B, Potempa B, Enghild JJ, Prossnitz ER, Blom AM, Potempa J.

J Biol Chem. 2014 Nov 21;289(47):32481-7. doi: 10.1074/jbc.C114.617142. Epub 2014 Oct 16.

9.

Detection and quantification of citrullinated chemokines.

Moelants EA, Van Damme J, Proost P.

PLoS One. 2011;6(12):e28976. doi: 10.1371/journal.pone.0028976. Epub 2011 Dec 16.

10.

Suppression of inflammatory responses of human gingival fibroblasts by gingipains from Porphyromonas gingivalis.

Palm E, Khalaf H, Bengtsson T.

Mol Oral Microbiol. 2015 Feb;30(1):74-85. doi: 10.1111/omi.12073. Epub 2014 Sep 19.

PMID:
25055828
11.

Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.

Konig MF, Paracha AS, Moni M, Bingham CO 3rd, Andrade F.

Ann Rheum Dis. 2015 Nov;74(11):2054-61. doi: 10.1136/annrheumdis-2014-205385. Epub 2014 May 26.

12.

Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines.

Moelants EA, Mortier A, Grauwen K, Ronsse I, Van Damme J, Proost P.

Cytokine. 2013 Jan;61(1):161-7. doi: 10.1016/j.cyto.2012.09.011. Epub 2012 Oct 15.

PMID:
23075670
13.

Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.

Proost P, Loos T, Mortier A, Schutyser E, Gouwy M, Noppen S, Dillen C, Ronsse I, Conings R, Struyf S, Opdenakker G, Maudgal PC, Van Damme J.

J Exp Med. 2008 Sep 1;205(9):2085-97. doi: 10.1084/jem.20080305. Epub 2008 Aug 18.

14.

Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.

Gawron K, Bereta G, Nowakowska Z, Lazarz-Bartyzel K, Lazarz M, Szmigielski B, Mizgalska D, Buda A, Koziel J, Oruba Z, Chomyszyn-Gajewska M, Potempa J.

Mol Oral Microbiol. 2014 Dec;29(6):321-32. doi: 10.1111/omi.12081. Epub 2014 Oct 21.

15.

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.

Loos T, Mortier A, Gouwy M, Ronsse I, Put W, Lenaerts JP, Van Damme J, Proost P.

Blood. 2008 Oct 1;112(7):2648-56. doi: 10.1182/blood-2008-04-149039. Epub 2008 Jul 21.

16.
17.

Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).

Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J.

PLoS Pathog. 2013 Sep;9(9):e1003627. doi: 10.1371/journal.ppat.1003627. Epub 2013 Sep 12.

18.

Secreted gingipains from Porphyromonas gingivalis colonies exert potent immunomodulatory effects on human gingival fibroblasts.

Bengtsson T, Khalaf A, Khalaf H.

Microbiol Res. 2015 Sep;178:18-26. doi: 10.1016/j.micres.2015.05.008. Epub 2015 Jun 6.

19.

The role of phagocytosis, oxidative burst and neutrophil extracellular traps in the interaction between neutrophils and the periodontal pathogen Porphyromonas gingivalis.

Jayaprakash K, Demirel I, Khalaf H, Bengtsson T.

Mol Oral Microbiol. 2015 Oct;30(5):361-75. doi: 10.1111/omi.12099. Epub 2015 May 4.

PMID:
25869817
20.

There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis.

Gabarrini G, Palma Medina LM, Stobernack T, Prins RC, du Teil Espina M, Kuipers J, Chlebowicz MA, Rossen JWA, van Winkelhoff AJ, van Dijl JM.

Virulence. 2018 Jan 1;9(1):456-464. doi: 10.1080/21505594.2017.1421827.

Supplemental Content

Support Center